Flavonoids are natural compounds which exhibit anticancer activities including antiproliferation,cell cycle arrest and apoptosis induction. Furthermore, flavonoids can inhibit cancer-related inflammation, angiogenesis, metastasis and multidrug resistance. The molecular mechanisms of these actions are associated with the blockage of cell signaling
transduction and NFkB-dependent gene expression. The mitochondrial damage affecting cellular energetic state also plays an important role in the anticancer mechanisms of flavonoids. In addition to direct actions on cancer cells, flavonoids can suppress immune response and VEGF release of vascular smooth muscle cells resulting in the inhibition of cancer-related inflammation and angiogenesis, respectively. Therefore, flavonoids are potential
compounds for cancer treatment through apoptotic induction, inhibition of cancer progress and overcoming multidrug resistance. This information is important for the development of anticancer drug derived from flavonoids.
1.Crozier A, Burns J, Aziz AA, Stewart AJ, Rabiasz HS, Jenkins GI, et al. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol Res 2000;33:79-88.
2.Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry 2000;55:481-504.
3.Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
4.Pierpoint WS. Flavonoids in the human diet. Prog Clin Biol Res 1986;213:125-40.
5.Dechsupa S, Kothan S, Vergote J, Leger G, Martineau A, Berangeo S, et al. Quercetin, Siamois 1 and Siamois 2 induce apoptosis in human breast cancer MDA-mB-435 cells xenograft in vivo. Cancer Biol Ther 2007;6:56-61.
6.Galati
G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 2004;37:287-303.
7.Kothan S, Dechsupa S, Leger G, Moretti JL, Vergote J, Mankhetkorn S. Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562
and K562/adr cells. Can J Physiol Pharmacol 2004;82:1084-90.
8.Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63:1035-42.
9.Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J
1995;9:200-9.
10.Sun AY, Chen YM. Oxidative stress and neurodegenerative disorders. J Biomed Sci 1998;5:401-14.
11.Suttana W, Mankhetkorn S, Poompimon W, Palagani A, Zhokhov S, Gerlo S, et al. Differential chemosensitization of P-glycoprotein overexpressing
K562/Adr cells by withaferin A and Siamois polyphenols. Molecular cancer 2010;9:99.
12.Constantinou A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 1990;50:2618-24.
13.Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ, et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 1999;128:999-1010.
14.Beltz LA, Bayer DK, Moss AL, Simet
IM. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006;6:389-406.
15.Kundu JK, Surh YJ. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Ann N Y Acad Sci 2007;1095:504-12.
16.Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007;2007:45673.
17.Michalak K, Wesolowska O. Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins. Anticancer Agents Med Chem 2012;12:880-90.
18.Edwards JM, Raffauf RF, Le Quesne PW. Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. J
Nat Prod 1979;42:85-91.
19.Molnar J, Beladi I, Domonkos K, Foldeak S, Boda K, Veckenstedt A. Antitumor activity of flavonoids on NK/Ly ascites tumor cells. Neoplasma 1981;28:11-8.
20.Kobayashi T, Nakata T, Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate
cancer cells. Cancer Lett 2002;176:17-23.
21.Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007;245:232-41.
22.Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol In Vitro 2009;23:797-807.
23.Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH. Inactivation of NF-kappaB by genistein is mediated via Akt
signaling pathway in breast cancer cells. Oncogene 2003;22:4702-9.
24.Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu MN, Boone E, Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 2006;66:4852-62.
25.Hollman PCH. Absorption, Bioavailability, and Metabolism of Flavonoids. Pharm Biol 2004;42:74�83.
26.Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000;45:528-37.
27.Gewies A. Introduction to Apoptosis. Aporeview 2003; 1: 1-26.
28.Denault JB, Salvesen GS. Caspases: keys in the ignition of cell death. Chem Rev 2002;102:4489-500.
29.Yin J, Xie X, Jia Q, Wang J, Huang G, Zou C,
et al. [Effect and mechanism of quercetin on proliferation and apoptosis of human osteosarcoma cell U-2OS/MTX300]. Zhongguo Zhong Yao Za Zhi. 2012;37:611-4.
30.Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and
caspase-3 in leukaemia HL-60 cells. Eur J Cancer 1999;35:1517-25.
31.Luo H, Rankin GO, Li Z, Depriest L, Chen YC. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem 2011;128:513-9.
32.Basu A, Haldar S. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Int J Oncol 2009;34:281-6.
33.Siegelin MD, Gaiser T, Habel A, Siegelin Y. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neurosci Lett 2009;454:223-8.
34.Siegelin MD, Gaiser T, Habel A, Siegelin Y. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Cancer Lett 2009;283(2):230-8.
35.Onoda C, Kuribayashi K, Nirasawa S, Tsuji N, Tanaka M, Kobayashi D, et al. (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int J Oncol 2011;38:1403-8.
36.Lin HY, Hou SC, Chen SC, Kao MC, Yu CC, Funayama S, et al. (-)-Epigallocatechin gallate induces
Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. J Agric Food Chem 2012;60:2480-9.
37.Berindan-Neagoe I, Braicu C, Tudoran O, Balacescu O, Irimie A. Early apoptosis signals induced by a low dose of epigallocatechin
3-gallate interfere with apoptotic and cell death pathways. J Nanosci Nanotechnol 2012;12:2113-9.
38.Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, et al. Molecular Biology of the Cell. 5th ed. New York: WH Freeman; 2004.
39.Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005;65:3980-5.
40.Zheng PW, Chiang LC, Lin CC. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci 2005;76:1367-79.
41.Chen Q, Liu S, Chen J, Zhang Q, Lin S, Chen Z, et al. Luteolin induces mitochondria-dependent apoptosis in human lung adenocarcinoma cell. Nat Prod Commun 2012;7:29-32.
42.Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, et al. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade
through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 2010;33:1181-91.
43.Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18:2195-224.
44.Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB
transcription factors. Oncogene 1999;18:6910-24.
45.Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
46.Lim YC, Cha YY. Epigallocatechin-3-gallate induces growth inhibition
and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol 2011;104:776-80.
47.Terra X, Valls J, Vitrac X, Merrillon JM, Arola L, Ardevol A, et al. Grape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7
macrophages by inhibiting NFkB signaling pathway. J Agric Food Chem 2007;55:4357-65.
48.Oak MH, Bedoui JE, Madeira SV, Chalupsky K, Schini-Kerth VB. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br J Pharmacol 2006;149:283-90.
49.Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615-27.
50.Imai Y, Yoshimori M, Fukuda K, Yamagishi H, Ueda Y. The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP
translocation. Oncol Rep 2012 ;27:1703-9.
51.Mercader AG, Pomilio AB. (Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies. Curr Med Chem 2012;19:4324-47.
A comparison in Newborns of the In situ Duration, Phlebitis and Daily Needle Cost of Scalp Intravenous Uning Steel Needles vs. Intravenous Catheters (���º��º�������������·ҧ��ʹ���ʹ����ǹ���º���dz�����㹼����·�á�á�Դ�����ҧ������硡Ѻ������ʵԡ
����������Ҥ��������Դ��ʹ���ʹ���ѡ�ʺ����ҤҢͧ�����������ѹ)
Update Treatment for Osteoporosis (Update Treatment for Osteoporosis)
Solitary Pulmonary Nodule : Evaluation and Management (�������㹻ʹ : ��ô�������ѡ��)
